Related Experiment Video

Updated: Jun 14, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus

Manabu Morishima1, Akira Marui, Shigeki Yanagi

  • 1Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Interactive Cardiovascular and Thoracic Surgery
|April 3, 2010
PubMed

Insights

A novel biodegradable hydrogel glue loaded with vancomycin effectively prevented methicillin-resistant Staphylococcus aureus (MRSA) prosthetic graft infections in a rat model. This new-glue offers a promising localized drug delivery system for cardiovascular surgery.

Area of Science:

  • Biomaterials Science
  • Infectious Disease Research
  • Cardiovascular Surgery

Background:

  • Prosthetic graft infections caused by methicillin-resistant Staphylococcus aureus (MRSA) pose a significant threat in cardiovascular surgery.
  • Current prevention strategies for graft infections are limited, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To evaluate the efficacy of a new biodegradable hydrogel glue as a sustained-release carrier for vancomycin in preventing MRSA prosthetic graft infections.
  • To assess the antimicrobial activity and drug release profile of the vancomycin-loaded hydrogel glue.

Main Methods:

  • A rat subcutaneous graft infection model was established using Dacron grafts and MRSA inoculation.
  • Experimental groups included no treatment, topical vancomycin, vancomycin-free hydrogel glue, and vancomycin-loaded hydrogel glue.
  • Graft infection levels were quantified by bacterial culture 7 days post-inoculation.

Main Results:

  • The vancomycin-loaded hydrogel glue significantly reduced MRSA quantities compared to all other groups (P<0.0001).
  • Approximately 95% of vancomycin was released from the hydrogel over 72 hours.
  • Achieved vancomycin tissue concentrations remained above the minimum inhibitory concentration for MRSA throughout the study period.

Conclusions:

  • The novel vancomycin-containing biodegradable hydrogel glue effectively prevents prosthetic graft infections.
  • This hydrogel glue demonstrates potential as a promising biodegradable drug delivery vehicle for localized antimicrobial therapy in surgical settings.

More Related Videos

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...